Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05932199 |
|---|---|
| Brief Title: | Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma |
| First Submitted : | June 27, 2023 |
| First Submitted that Met QC Criteria : | June 27, 2023 |
| First Posted : | July 6, 2023 |
| Last Update Submitted that Met QC Criteria : | January 12, 2024 |
| Last Update Posted : | January 16, 2024 |